Transparency Market Research Single User License: Etoposide Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024 Transparency Market Research State Tower, 90, State Street, Suite 700. Albany, NY 12207 United States www.transparencymarketresearch.com [email protected] USD 4315.5 Flat 10% Discount!! Report will be delivered with in 15-20 working days Free Customization as per your requirement You will get Custom Report at Syndicated Report price Request Sample Buy Now REPORT DESCRIPTION Transparency Market Research Reports incorporated a definite business overview and investigation inclines on “Etoposide Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024” This report likewise incorporates more illumination about fundamental review of the business including definitions, requisitions and worldwide business sector industry structure. Global Etoposide Market: Description Etoposide is a derivative of epipodophyllotoxins that are derived from Mandragora officianarum (plant). Its chemical name is 4'demethyl-epipodophylotoxin 9-[4,6-O-(R)-ethylidene-β-D-glucopyranoside] and it was introduced in the market in 1970. Currently, it is utilized extensively in manufacturing drugs that help treat various human malignant diseases such as testicular cancer, lymphomas (Hodgkin, non-Hodgkin), leukemia and lung cancer. Other diseases that are treated by consumption of etoposide include Ewing sarcoma, Kaposi disease, rhabdomyosarcoma, soft tissue sarcoma, pediatric brain tumors, gastric cancer, Wilms tumor, multiple myeloma, hepatoma, adenocarcinoma and uterine cancer. Etoposide acts by inhibiting the activity of topoisomerase II which is responsible for uncoiling of deoxyribonucleic acid (DNA) and thus affects the deoxyribonucleic acid (DNA) replication and repair. Etoposide is usually administered in combination with various antineoplastic drugs such as cisplatin that have different modes of action. Etoposide is administered in the patient’s body through oral and intravenous routes. Intravenous administration of etoposide is given under the supervision of a doctor since overdose of the same might result in malfunctioning of human body. Etoposide solution for injection is available in 5 mL vial, 25 mL vial and 50 mL vial, and the dose is 20 mg/mL. Etoposide injections are usually given to patients whose cancer condition have not improved or have worsened post radiation treatment or other medications. Interpret A Competitive Outlook Analysis Report With FREE PDF Brochure: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=12344 Global Etoposide Market: Major Products Etopophos, Toposar and Vepesid are some of the branded versions of the Etoposide. Among all these, Etopophos accounts for the largest revenue share in the total etoposide market. Rising incidence of lung cancer has been considered as one of the major factors driving the market for etoposide. According to the American Lung Association (ALA), an estimated 159,260 people with lung cancer are expected to die in the American region in 2014 that will account for approximately 27% of all cancer deaths in the same year. Also, increasing incidence of Ewing sarcoma will propel the growth of etoposide market. Global Etoposide Market: Drivers and Restraints The increasing number of acquired immune deficiency syndrome (AIDS) patients across the globe will further drive the growth of etoposide market as people with AIDS are at the high risk of developing Kaposi’s sarcoma. It has been estimated by the World Health Organization that in 2012, around 35.3 million people were living with AIDS worldwide; of these around 1.6 million people died. AIDS also increases the risk for Hodgkin and non-Hodgkin syndrome. Increasing number of patients suffering with gastric cancer will also augment the growth of etoposide market. Various epidemiological sources indicate that around 1 million people suffer from gastric cancer every year across the globe. Despite all the advantages, the growth of etoposide market might get hampered due to the side effects associated with the administration of etoposide. Difficulty in breathing or swallowing, seizures, hives, constipation, hair loss and unusual tiredness or weakness are some of the side-effects that are associated with etoposide. Global Etoposide Market: Geographical Dynamics North America accounted for the largest revenue share of the total etoposide market in 2012 owing to the presence of major manufacturing companies in the region along with the improving governmental initiatives for the development and manufacturing of etoposide. Asia-Pacific is expected to show highest CAGR during the forecast period. This growth is attributed to rising incidences of various diseases such as uterine cancer, multiple myeloma, hepatoma and lymphoma in the region. Increasing government funding for the R&D of etoposide will further drive the growth of etoposide market in the region. Major players operating in the market includes Pharmedic Laboratories Pvt. Ltd, Teva Pharmaceutical Industries Ltd, Ben Venue Laboratories, and Accord Healthcare, Inc. among other significant players. The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications. Browse the full Research report at : http://www.transparencymarketresearch.com/etoposide-market.html The study is a source of reliable data on: • Market segments and sub-segments • Market trends and dynamics • Supply and demand • Market size • Current trends/opportunities/challenges • Competitive landscape • Technological breakthroughs • Value chain and stakeholder analysis The regional analysis covers: • North America (U.S. and Canada) • Latin America (Mexico, Brazil, Peru, Chile, and others) • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, Luxembourg) • Eastern Europe (Poland, Russia) • Asia Pacific (China, India, Japan, ASEAN, Australia and New Zealand) • Middle East and Africa (GCC, Southern Africa, North Africa) The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain. A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period. Highlights of the report: • A complete backdrop analysis, which includes an assessment of the parent market • Important changes in market dynamics • Market segmentation up to the second or third level • Historical, current, and projected size of the market from the standpoint of both value and volume • Reporting and evaluation of recent industry developments • Market shares and strategies of key players • Emerging niche segments and regional markets • An objective assessment of the trajectory of the market • Recommendations to companies for strengthening their foothold in the market Read More Reports On Chemical Market : http://www.transparencymarketresearch.com/chemical-market-reports2.html About Us Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge. Latest Press Release Reports : http://www.transparencymarketresearch.com/press-releases.htm Latest Articles Reports : http://www.transparencymarketresearch.com/articles.htm Contact: Transparency Market Research 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-552-3453 Email: [email protected] Website: http://www.transparencymarketresearch.com/ Browse Market Research Blog : http://globalresearchanalysis.blogspot.in/
Etoposide is utilized extensively in manufacturing drugs that help treat various human malignant diseases such as testicular cancer, lymphomas (Hodgkin, non-Hodgkin), leukemia and lung cancer. Other diseases that are treated by consumption of etoposide include Ewing sarcoma, Kaposi disease, rhabdomyosarcoma, soft tissue sarcoma, pediatric brain tumors, gastric cancer, Wilms tumor, multiple myeloma, hepatoma, adenocarcinoma and uterine cancer.
© Copyright 2024 Paperzz
